title: Mutagen Synergy: Hypermutability Generated by Specific Pairs of Base Analogs.
abstract: We tested pairwise combinations of classical base analog mutagens in Escherichia coli to study possible mutagen synergies. We examined the cytidine analogs zebularine (ZEB) and 5-azacytidine (5AZ), the adenine analog 2-aminopurine (2AP), and the uridine/thymidine analog 5-bromodeoxyuridine (5BrdU). We detected a striking synergy with the 2AP plus ZEB combination, resulting in hypermutability, a 35-fold increase in mutation frequency (to 53,000 × 10(-8)) in the rpoB gene over that with either mutagen alone. A weak synergy was also detected with 2AP plus 5AZ and with 5BrdU plus ZEB. The pairing of 2AP and 5BrdU resulted in suppression, lowering the mutation frequency of 5BrdU alone by 6.5-fold. Sequencing the mutations from the 2AP plus ZEB combination showed the predominance of two new hot spots for A·T→G·C transitions that are not well represented in either single mutagen spectrum, and one of which is not found even in the spectrum of a mismatch repair-deficient strain. The strong synergy between 2AP and ZEB could be explained by changes in the dinucleoside triphosphate (dNTP) pools.
  
  
  
  Although mutagens have been widely studied, the mutagenic effects of combinations of mutagens have not been fully researched. Here, we show that certain pairwise combinations of base analog mutagens display synergy or suppression. In particular, the combination of 2-aminopurine and zebularine, analogs of adenine and cytidine, respectively, shows a 35-fold increased mutation frequency compared with that of either mutagen alone. Understanding the mechanism of synergy can lead to increased understanding of mutagenic processes. As combinations of base analogs are used in certain chemotherapy regimens, including those involving ZEB and 5AZ, these results indicate that testing the mutagenicity of all drug combinations is prudent.
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, and David Geffen School of Medicine, University of California, Los Angeles, California, USA.
authors.forename: Jocelyn
authors.initials: J
authors.lastname: Ang
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, and David Geffen School of Medicine, University of California, Los Angeles, California, USA.
authors.forename: Lisa Yun
authors.initials: LY
authors.lastname: Song
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, and David Geffen School of Medicine, University of California, Los Angeles, California, USA.
authors.forename: Sara
authors.initials: S
authors.lastname: D'Souza
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, and David Geffen School of Medicine, University of California, Los Angeles, California, USA.
authors.forename: Irene L
authors.initials: IL
authors.lastname: Hong
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, and David Geffen School of Medicine, University of California, Los Angeles, California, USA.
authors.forename: Rohan
authors.initials: R
authors.lastname: Luhar
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, and David Geffen School of Medicine, University of California, Los Angeles, California, USA.
authors.forename: Madeline
authors.initials: M
authors.lastname: Yung
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, and David Geffen School of Medicine, University of California, Los Angeles, California, USA jhmiller@microbio.ucla.edu.
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Miller
mesh_terms: D001374:Azacitidine / Q000737:chemistry / Q000633:toxicity*; D020029:Base Pairing / Q000187:drug effects*; D001973:Bromodeoxyuridine / Q000737:chemistry / Q000633:toxicity*; D003562:Cytidine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000633:toxicity; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism; D009153:Mutagens / Q000737:chemistry / Q000633:toxicity*; D009154:Mutation / Q000187:drug effects*
chemical_list: D029968:Escherichia coli Proteins; D009153:Mutagens; D003562:Cytidine; C009131:pyrimidin-2-one beta-ribofuranoside; D001973:Bromodeoxyuridine; D001374:Azacitidine